{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-027826","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.346825+00:00","generated_at":"2026-06-01T04:48:44.255121+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aadi Bioscience shareholders approve director elections, say-on-pay, and auditor ratification at 2024 annual meeting","bullets":["Elected Caley Castelein (9.95M for, 1.91M withheld) and Neil Desai (8.17M for, 3.68M withheld) as Class I directors.","Advisory vote on executive compensation passed with 8.97M for, 2.60M against, 282K abstentions.","Ratified BDO USA as independent auditor for FY 2024: 13.46M for, 635K against, 1.00M abstentions.","Total shares represented 15.1M, ~62% of voting power, establishing a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-027826","json":"https://secwatch.observer/filing/0001628280-24-027826.json","markdown":"https://secwatch.observer/filing/0001628280-24-027826.md","text":"https://secwatch.observer/filing/0001628280-24-027826.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000162828024027826/0001628280-24-027826-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000162828024027826/aadi-20240611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:48:44.255121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}